These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 6265549)
21. Experimental live tick-borne encephalitis vaccine (Labgat E5 "14" virus clone): volunteers 1 and 2 years after single-dose immunization. Mayer V; Orolin D; Pogády J; Stárek M; Kubistová K; Gajdosová E; Buran I Acta Virol; 1976 Jun; 20(3):215-25. PubMed ID: 9802 [TBL] [Abstract][Full Text] [Related]
22. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus. Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG mBio; 2019 Apr; 10(2):. PubMed ID: 31015334 [TBL] [Abstract][Full Text] [Related]
23. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus. Aberle JH; Aberle SW; Kofler RM; Mandl CW J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582 [TBL] [Abstract][Full Text] [Related]
24. Antigenic similarity of central European encephalitis and louping-ill viruses. Hubálek Z; Pow I; Reid HW; Hussain MH Acta Virol; 1995 Dec; 39(5-6):251-6. PubMed ID: 8722293 [TBL] [Abstract][Full Text] [Related]
25. Tick-borne encephalitis virus transmission between ticks cofeeding on specific immune natural rodent hosts. Labuda M; Kozuch O; Zuffová E; Elecková E; Hails RS; Nuttall PA Virology; 1997 Aug; 235(1):138-43. PubMed ID: 9300045 [TBL] [Abstract][Full Text] [Related]
26. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys. Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704 [TBL] [Abstract][Full Text] [Related]
27. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620 [TBL] [Abstract][Full Text] [Related]
28. Restricted replication of the E5"14" clone of Langat TP21 virus (from the tick-borne encephalitis complex) in CNS of subadult mice. Rajcáni J; Mayer V; Weismanová E Acta Virol; 1982 Dec; 26(6):488-96. PubMed ID: 6132543 [TBL] [Abstract][Full Text] [Related]
29. Dialysable specific transfer factor in mice immunized with attenuated Langat virus from the tick-borne encephalitis complex: generation, action and quantitative assay. Mayer V; Gajdosová E; Valásková M; Gombosová A; Oravec C Acta Virol; 1982 Dec; 26(6):453-65. PubMed ID: 6188353 [TBL] [Abstract][Full Text] [Related]
30. Potentiation of langat virus infection by lead intoxication--influence on host defenses. Thind IS; Singh NP Acta Virol; 1977 Jul; 21(4):317-25. PubMed ID: 20766 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers. Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289 [TBL] [Abstract][Full Text] [Related]
32. Cell-mediated immunity in flavivirus infections. I. Induction of cytotoxic T lymphocytes in mice by an attenuated virus from the tick-borne encephalitis complex and its group-reactive character. Gajdosová E; Oravec C; Mayer V Acta Virol; 1981 Jan; 25(1):10-8. PubMed ID: 6165230 [TBL] [Abstract][Full Text] [Related]
33. The highly attenuated E5"14" plaque-cloned derivative from the Langat TP21 E5 strain. Isolation and properties. Mayer V Acta Virol; 1973 May; 17(3):263. PubMed ID: 4147148 [No Abstract] [Full Text] [Related]
34. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893 [TBL] [Abstract][Full Text] [Related]
35. Vaccination of human volunteers against Russian spring-summer (RSS) virus complex with attenuated Langat E5 virus. Price WH; Thind IS; Teasdall RD; O'Leary W Bull World Health Organ; 1970; 42(1):89-94. PubMed ID: 5309521 [TBL] [Abstract][Full Text] [Related]
36. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model. Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903 [TBL] [Abstract][Full Text] [Related]